SteelPeak Wealth’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19K | Buy |
+15,304
| New | +$19K | ﹤0.01% | 502 |
|
|
2025
Q1 | – | Sell |
-10,236
| Closed | -$18.7K | – | 535 |
|
|
2024
Q4 | $18.7K | Buy |
+10,236
| New | +$18.7K | ﹤0.01% | 474 |
|
|
2024
Q2 | – | Sell |
-94,589
| Closed | -$355K | – | 487 |
|
|
2024
Q1 | $355K | Buy |
+94,589
| New | +$355K | 0.02% | 326 |
|
|
2023
Q3 | – | Sell |
-15,848
| Closed | -$211K | – | 429 |
|
|
2023
Q2 | $211K | Buy |
+15,848
| New | +$211K | 0.01% | 366 |
|
|
2021
Q4 | – | Sell |
-14,003
| Closed | -$358K | – | 419 |
|
|
2021
Q3 | $358K | Buy |
14,003
+6,951
| +99% | +$178K | 0.02% | 287 |
|
|
2021
Q2 | $247K | Buy |
+7,052
| New | +$247K | 0.02% | 354 |
|